264 related articles for article (PubMed ID: 38545841)
1. Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy.
Guan A; Wong JJ
Cancer Med; 2024 Apr; 13(7):e6989. PubMed ID: 38545841
[TBL] [Abstract][Full Text] [Related]
2. The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer.
Xu X; Zhao J; Yang M; Han L; Yuan X; Chi W; Jiang J
Eur J Med Res; 2023 Nov; 28(1):475. PubMed ID: 37915103
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of RNA modification N6-methyladenosine in human cancer.
Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.
Xu Z; Peng B; Cai Y; Wu G; Huang J; Gao M; Guo G; Zeng S; Gong Z; Yan Y
Biochem Pharmacol; 2020 Dec; 182():114258. PubMed ID: 33017575
[TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
Front Oncol; 2021; 11():726018. PubMed ID: 35299934
[TBL] [Abstract][Full Text] [Related]
7. RNA methylation-related inhibitors: Biological basis and therapeutic potential for cancer therapy.
Chen H; Liu H; Zhang C; Xiao N; Li Y; Zhao X; Zhang R; Gu H; Kang Q; Wan J
Clin Transl Med; 2024 Apr; 14(4):e1644. PubMed ID: 38572667
[TBL] [Abstract][Full Text] [Related]
8. The role of m6A RNA methylation in cancer.
Sun T; Wu R; Ming L
Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
Liang Z; Kidwell RL; Deng H; Xie Q
Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
[TBL] [Abstract][Full Text] [Related]
11. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types.
Shen S; Zhang R; Jiang Y; Li Y; Lin L; Liu Z; Zhao Y; Shen H; Hu Z; Wei Y; Chen F
Mol Cancer; 2021 Apr; 20(1):67. PubMed ID: 33849552
[TBL] [Abstract][Full Text] [Related]
13. The role of N
Wang K; Wang L; Chen X; Gu J; Cheng X
Epigenomics; 2023 Nov; 15(22):1221-1232. PubMed ID: 38009226
[TBL] [Abstract][Full Text] [Related]
14. Research progress of N6-methyladenosine in colorectal cancer: A review.
Lin Y; Shi H; Wu L; Ge L; Ma Z
Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
[TBL] [Abstract][Full Text] [Related]
15. Regulatory effects of natural products on N6-methyladenosine modification: A novel therapeutic strategy for cancer.
Mao-Mao ; Zhang JJ; Xu YP; Shao MM; Wang MC
Drug Discov Today; 2024 Feb; 29(2):103875. PubMed ID: 38176674
[TBL] [Abstract][Full Text] [Related]
16. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
[TBL] [Abstract][Full Text] [Related]
17. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
[TBL] [Abstract][Full Text] [Related]
18. Functions of RNA N6-methyladenosine modification in cancer progression.
Chen B; Li Y; Song R; Xue C; Xu F
Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972
[TBL] [Abstract][Full Text] [Related]
19. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
[TBL] [Abstract][Full Text] [Related]
20. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
